The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase 2 non-inferiority trial of (Z)-endoxifen and exemestane + goserelin as neoadjuvant treatment for premenopausal women with ER+/HER2- breast cancer (EVANGELINE).
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); bioTheranostics (Inst); Blueprint Medicines (Inst); Genzyme (Inst); Lilly (Inst); Rna Diagnostics (Inst); Seagen (Inst)
Research Funding - Lilly (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly
 
Vera Jean Suman
Research Funding - Atossa Therapeutics (Inst)
 
Lida A. Mina
No Relationships to Disclose
 
Pooja Prem Advani
Stock and Other Ownership Interests - Abbvie (I); Alpha2 Pharmaceuticals (I); NanoString Technologies (I); Sorrento Therapeutics (I)
Honoraria - Ascentage Pharma Group (I); AstraZeneca (I)
Consulting or Advisory Role - Ascentage Pharma (I); AstraZeneca (I); BMS (I); Puma Biotechnology
Research Funding - Agendia; Ascentage Pharma (I); AstraZeneca (Inst); Atossa Therapeutics (Inst); Ayala Pharmaceuticals (Inst); Bristol Myer Squibb (I); Caris Life Sciences (Inst); Genentech/Roche; Gilead Sciences (Inst); Seagan (Inst)
Patents, Royalties, Other Intellectual Property - patent pending on PCT-US2020-067237 (cancer vaccine platform) (I)
Travel, Accommodations, Expenses - Caris Life Sciences; Tempus (I)
 
John George Knecht
Employment - Cardinal Health; CLS Health; Incyte
Leadership - Kindred Hospital Clear Lake
Stock and Other Ownership Interests - Becton Dickinson; Checkpoint Therapeutics; Fortress Biotech; Myovant Sciences; Reviva Pharmaceuticals
Honoraria - OMNI Health Media
Research Funding - Atossa Therapeutics; Cosmo Pharmaceuticals; EQRx; Phanes Therapeutics; Takeda; Xilio Therapeutics
Travel, Accommodations, Expenses - Cardinal Health
 
Heather Heather Fraser
Employment - Atossa Therapeutics
 
Steven Carl Quay
Employment - Atossa Therapeutics